MedPath

XYLONOR

XYLONOR

Approved
DIN Number

02218607

Drug Class

Human

Market Date

Mar 26, 1997

Company
HC

Septodont

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02218607
AIG Number0228602001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
N01BB52 LIDOCAINE, COMBINATIONS
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationBuccal
AHFS Classification72:00.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

CETRIMIDEActive
Strength: 150 MG / 100 G
Monograph: CETRIMIDE
LIDOCAINEActive
Strength: 15 G / 100 G
Monograph: LIDOCAINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.